首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Paediatric central nervous system tumours in a New Zealand population: a 10-year experience of epidemiology, management strategies and outcomes.
【24h】

Paediatric central nervous system tumours in a New Zealand population: a 10-year experience of epidemiology, management strategies and outcomes.

机译:新西兰人群的小儿中枢神经系统肿瘤:流行病学,管理策略和结果的10年经验。

获取原文
获取原文并翻译 | 示例
           

摘要

We analysed 166 cases of paediatric central nervous system tumour presenting to Auckland City and Starship Children's Hospital, New Zealand, between 1995 and 2004. The purpose of this study was to perform an audit of paediatric neurosurgical practice in the upper North Island of New Zealand with the objective of assessing patient presentation, demographics, and modality and efficacy of therapy. The overall incidence of central nervous system tumours was 3.42/100,000/year. The incidence rate of medulloblastoma for Maori was over double that for European New Zealanders. Tumour clearance was attempted in 81.3% of patients. Some type of adjunct therapy was received by 45.2% of patients. Overall, 60.8% of patients had satisfactory or good results. Survival rates for pilocytic astrocytoma and ependymoma were consistent with previous studies. Survival data for medulloblastoma demonstrate improved outcomes with complete resection of tumour and with a specialist paediatric neurosurgeon compared with general neurosurgeons. Recent management changes have led to improved outcomes.
机译:我们分析了1995年至2004年间向奥克兰市和新西兰星舰儿童医院呈报的166例小儿中枢神经系统肿瘤的情况。本研究的目的是对新西兰北岛上层的小儿神经外科实践进行审计。目的是评估患者的表现,人口统计学以及治疗的方式和功效。中枢神经系统肿瘤的总发病率为3.42 / 100,000 /年。毛利人的髓母细胞瘤的发病率是欧洲新西兰人的两倍。尝试清除81.3%的患者的肿瘤。 45.2%的患者接受了某种类型的辅助治疗。总体而言,有60.8%的患者结果令人满意或良好。毛细胞星形细胞瘤和室管膜瘤的生存率与以前的研究一致。髓母细胞瘤的生存数据表明,与普通神经外科医生相比,完全切除肿瘤和专科儿科神经外科医生可以改善预后。最近的管理变化已导致成果改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号